Rolling Stone
SPECIAL REPORT
Marketing a Phony “Miracle” Drug
By Ben Wallace-Wells
Zyprexa was created to treat schizophrenia, but it wound up being used on depressed moms and misbehaving kids. How one of the nation’s biggest pharmaceutical companies turned a flawed, dangerous pill into a multi-billion-dollar bonanza — and who paid the price.
Philadelphia Inquirer
Whistle-blower’s perspective on Lilly case
By Miriam Hill
Robert Rudolph knew he was about to end his lucrative career at Eli Lilly & Co., but he had to say something.
Why, he asked management, was the Indianapolis pharmaceutical company marketing its antipsychotic drug Zyprexa to elderly people when the drug was not approved for that [...]
Wall Street Journal
Lilly Reaches Zyprexa Settlement
By KERRY E. GRACE
Eli Lilly & Co. agreed to pay $1.42 billion in a long-awaited settlement with federal prosecutors regarding allegations of improperly marketing its blockbuster antipsychotic drug Zyprexa.
A resolution has been expected since October, when the Indianapolis drug maker announced it was in “advanced discussions” and had set [...]
U.S. Department of Justice
United States Attorney
Eastern District of Pennsylvania
615 Chestnut Street
Suite 1250
Philadelphia, Pennsylvania 19106-4476
(215) 861-8200
For Immediate Release January 15, 2009
PHARMACEUTICAL COMPANY ELI LILLY TO PAY RECORD
$1.415 BILLION FOR OFF-LABEL DRUG MARKETING
Criminal Penalty is Largest Individual Corporate Criminal Fine
PHILADELPHIA – United States Attorney General Michael B. Mukasey and Acting United States Attorney Laurie Magid today announced [...]
U.S. Department of Justice
United States Attorney
Eastern District of Pennsylvania
615 Chestnut Street
Suite 1250
Philadelphia, Pennsylvania 19106-4476
(215) 861-8200
For Immediate Release January 15, 2009
PHARMACEUTICAL COMPANY ELI LILLY TO PAY RECORD
$1.415 BILLION FOR OFF-LABEL DRUG MARKETING
Criminal Penalty is Largest Individual Corporate Criminal Fine
PHILADELPHIA – United States Attorney General Michael B. Mukasey and Acting United States Attorney Laurie Magid today announced [...]
New York Times
By GARDINER HARRIS
Eli Lilly, the drug company, is expected to agree as soon as Thursday to pay $1.4 billion to settle criminal and civil charges that it illegally marketed its blockbuster antipsychotic drug Zyprexa for unauthorized use in patients particularly vulnerable to its risky side effects.
The amount of the settlement is a record [...]
